Search
for
Sort by
Research 91–120 of 1000+
- Immune Dysregulation in Chronic Inflammatory Skin Disorders: An Integrative Immunopathological Review
- Adipose tissue remodeling via TSLP-mediated IL-4/IL-13 signaling: Implications for atopic dermatitis and skin barrier
- SIRT1 downregulation provokes immune-inflammatory responses in hair follicle outer root sheath cells and may contribute to development of alopecia areata
- Hair follicle–derived IL-7 and IL-15 mediate skin-resident memory T cell homeostasis and lymphoma
- Skin CD4+ memory T cells exhibit combined cluster-mediated retention and equilibration with the circulation
- Recognition and management of <i>Staphylococcus aureus</i> toxin‐mediated disease
- Erlotinib-Induced Skin Inflammation Is IL-1 Mediated in KC-Tie2 Mice and Human Skin Organ Culture
- Identification of Distinct Immune Signatures and Chemokine Networks in Scalp Inflammatory Diseases
- Frontal Fibrosing Alopecia. An Example of Disrupted Aryl Hydrocarbon Receptor-Mediated Immunological Homeostasis in the Skin?
- SOCS3 treatment prevents the development of alopecia areata by inhibiting CD8+ T cell-mediated autoimmune destruction
- 27 Preclinical ex vivo and in vivo evidence supporting selective inhibition of tyrosine kinase 2-dependent, IL-12-mediated signaling as a novel pharmacological strategy for alopecia areata management
- Alopecia Areata
- Alopecia areata update
- Alopecia areata
- Skin manifestations of celiac disease
- Probiotic Bacteria Induce a ‘Glow of Health’
- Overview of Alopecia Areata
- The genetics of alopecia areata: New approaches, new findings, new treatments
- Inhibiting Janus kinases to treat alopecia areata
- Marie Antoinette Syndrome
- Frontal fibrosing alopecia shows robust T helper 1 and Janus kinase 3 skewing
- Topical immunomodulators in dermatology.
- Primary Scarring Alopecias
- An update of the pathogenesis of frontal fibrosing alopecia: What does the current evidence tell us?
- Systemic lupus erythematosus in a filly.
- Inhibidores de JAK: usos en dermatología. Parte 1: generalidades, aplicaciones en vitíligo y en alopecia areata
- Janus Kinase Inhibitors in Dermatology: Part 1 — General Considerations and Applications in Vitiligo and Alopecia Areata
- New developing multiple sclerosis in a patient using tofacitinib due to alopesia areata
- The future of vitamin D in dermatology.
- Alopecia areata – Current understanding and management